6.8(top 2%)
Impact Factor
7.1(top 2%)
extended IF
78(top 5%)
H-Index
1.7K
authors
1.6K
papers
36.2K
citations
3.8K
citing journals
29.2K
citing authors

Most Cited Articles of CNS Neuroscience and Therapeutics

TitleYearCitations
Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings)2013317
REVIEW: Curcumin and Alzheimer's disease2010295
The pharmacology of lysergic acid diethylamide: a review2008255
A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?2011243
Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment2017239
Dopamine and oxytocin interactions underlying behaviors: potential contributions to behavioral disorders2010232
Post-traumatic stress disorder in Canada2008193
The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD)2009192
Altered processing of contextual information during fear extinction in PTSD: an fMRI study2011190
Excessive autophagy contributes to neuron death in cerebral ischemia2012185
Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome2016178
REVIEW: Neurosyphilis: A historical perspective and review2010176
The antiapoptotic activity of melatonin in neurodegenerative diseases2009176
The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties2008171
Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases2008171
REVIEW: Oxytocin: Crossing the bridge between basic science and pharmacotherapy2010168
Tight junction in blood-brain barrier: an overview of structure, regulation, and regulator substances2012166
Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders2012166
All roads to schizophrenia lead to dopamine supersensitivity and elevated dopamine D2(high) receptors2011160
Cannabidiol: a promising drug for neurodegenerative disorders?2009152
Vilazodone: a 5-HT1A receptor agonist/serotonin transporter inhibitor for the treatment of affective disorders2009152
Oxytocin levels in social anxiety disorder2008152
BNIP3 interacting with LC3 triggers excessive mitophagy in delayed neuronal death in stroke2014146
RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms2010140
Seizures and epilepsy in Alzheimer's disease2012139